Foundation Medicine (FMI) Misses Q3 EPS by 4c, Offers FY15 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. SPY
9. SBUX
10. AXP

Go back to Foundation Medicine (FMI) Misses Q3 EPS by 4c, Offers FY15 Guidance

Foundation Medicine Announces 2015 Third Quarter Results and Recent Highlights

November 3, 2015 4:00 PM EST

Year-over-Year Third Quarter Revenues Grow 54%; FoundationCORE Expands to Approximately 60,000 Patient Cases; ctDNA Product Launch on Track

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Foundation Medicine, Inc. (NASDAQ: FMI) today reported financial and operating results for its third quarter ended September 30, 2015. Highlights for the quarter included:

Third quarter revenue of $25.4 million, 54% year-over-year growth; Third quarter revenue from biopharmaceutical customers of $11.7 million, 75% year-over-year growth;... More